BMY Bristol-Myers Squibb Company
BMY Bristol-Myers Squibb Company
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $57.21 · VWAP $57.04 · +7.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
BMY Price Structure
Loading timeframes…
Peers
Every watchlist BMY belongs to, members best 30-day change first — BMY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech
Against street estimates
How BMY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about BMY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 35 days ago · Sep 18
- Bristol Myers Squibb Posts Strong Q2 2026 Results ...
- Bristol Myers Squibb (BMY) Earnings Date and Reports 2026
- Bristol Myers Squibb Q2 2026 Results Boost Guidance
- Bristol-Myers Squibb Company (BMY) Share Price Live | US Stock Data & Chart
- Bristol-Myers Squibb Company (BMY) Live Share Price, Invest From India
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
BMY research tape
36 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.